These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12610757)

  • 1. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
    Linazasoro G
    Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
    Arias-Carrión O; Yuan TF
    Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for a curative cell therapy in Parkinson's disease.
    Laguna Goya R; Tyers P; Barker RA
    J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.
    Harrower TP; Tyers P; Hooks Y; Barker RA
    Exp Neurol; 2006 Jan; 197(1):56-69. PubMed ID: 16246328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapy for Parkinson's disease: problems and prospects.
    Björklund A
    Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal cell replacement in Parkinson's disease.
    Hedlund E; Perlmann T
    J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
    Kordower JH; Goetz CG; Freeman TB; Olanow CW
    Exp Neurol; 1997 Mar; 144(1):41-6. PubMed ID: 9126150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease.
    Fernandez-Espejo E; Armengol JA; Flores JA; Galan-Rodriguez B; Ramiro S
    Brain Res Brain Res Rev; 2005 Sep; 49(2):343-54. PubMed ID: 16111561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell therapy for Parkinson's disease.
    Takahashi J
    Expert Rev Neurother; 2007 Jun; 7(6):667-75. PubMed ID: 17563250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease.
    Morizane A; Li JY; Brundin P
    Cell Tissue Res; 2008 Jan; 331(1):323-36. PubMed ID: 18034267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.